Cancer Research
A comprehensive analysis of nearly 1,600 tumor samples has found that CT-X genes are expressed in nearly half the breast cancers that lack the estrogen receptor (ER). CT-X gene products are the targets of therapeutic cancer vaccines already in phase III clinical trials for lung cancer and melanoma.
A research project is currently in progress that focuses on tumour stem cells and their division. Until recently, no one had any idea of the existence of these types of cells, even though they can play a crucial role in the formation of tumours.
LA JOLLA, Calif., July 24, 2009 -- Scientists at Burnham Institute for Medical Research (Burnham) have found that the Caspase-8 protein, long known to play a major role in promoting programmed cell death (apoptosis), helps relay signals that can cause cancer cells to proliferate, migrate and invade surrounding tissues.
WEST LAFAYETTE, Ind. -Purdue University researchers have created magnetically responsive gold nanostars that may offer a new approach to biomedical imaging.
RICHMOND, Va. (July 20, 2009) -- Two genes may contribute to chemotherapy resistance in drugs like 5-fluorouracil, which is used in liver cancer treatment, according to Virginia Commonwealth University Massey Cancer Center researchers.
CHICAGO -- Transoral (through-the-mouth) laser surgery to remove cancer at the base of the tongue is as effective as more invasive open surgery and may improve quality of life according to a new study by Rush University Medical Center. The study is published in the July issue of the scientific journal Otolaryngology ?Head and Neck Surgery.
PHILADELPHIA -- Endothelial progenitor cells may play a role in the start and progression of metastatic disease in children with cancer, according to study results published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
(PHILADELPHIA) Researchers from the Kimmel Cancer Center at Jefferson have identified a protein relationship that may be an ideal treatment target for ER+ breast cancer. The study was reported in the July 15 issue of Cancer Research.
LEXINGTON, Ky. (July 13, 2009) -- Researchers at the University of Kentucky Markey Cancer Center and Graduate Center for Toxicology (GCT) have gained new insight into the genetic mechanisms underlying Huntington's disease and other neurodegenerative or neuromuscular disorders caused by trinucleotide repeats (or TNRs) in DNA.
WASHINGTON, D.C. -- The American Association for Cancer Research applauds President Obama's nomination of Francis S. Collins, M.D., Ph.D., to be the 16th director of the National Institutes of Health (NIH).
PHILADELPHIA -- Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.
SEATTLE -- The relationship between migraine headaches in women and a significant reduction in breast cancer risk has been confirmed in a follow-on study to landmark research published last year and conducted by scientists at Fred Hutchinson Cancer Research Center.
A spate of articles have been published recently concerning the effects of Green Tea on prostate cancer. The following discussion of the science, as well as the media response, is taken from my blog at Blue-Genes.net - please subscribe there, as I'm not sure whether I will continue to copy my posts here. N.B. the press release is also featured on Scienceblog here. Click here to read original post
Specific variations or mutations in a particular can gene raise a man's risk of familial, or inherited, testicular germ-cell cancer, the most common form of this disease, according to new research by scientists at the National Institutes of Health.
PHILADELPHIA -- According to results of a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, men with prostate cancer who consumed the active compounds in green tea demonstrated a significant reduction in serum markers predictive of prostate cancer progression.
